If the new drugs are designed to resensitize Serotonin 2C receptors the drug addiction can be reversed. These receptors do not work well in drug addicts.
Serotonin 2C receptors have been found to have weakened signaling when it comes to those who use drugs quite often like- addicts. If the new drugs can restore that weakened signaling, then drug addiction can be reversed finds a new study. The findings of this study are published in the Journal of Medicinal Chemistry. Researchers from The University of Texas Medical Branch at Galveston developed and tested a treatment on rats and found it effective in reducing the animals' cravings. Their findings are in the Journal of Medicinal Chemistry.
‘New drugs have to be designed to reverse chemical imbalances made to the drug abuser𠏋 brain by his drug habit.’
When someone habitually misuses drugs, their brain chemistry is changed in ways that make it harder for them to quit taking drugs despite negative consequences. Once someone has developed this brain disorder, their mind pays sharper attention to cues that encourage drug use, making it harder for them to abstain.Serotonin, a brain chemical that transmits information between neural regions, is a key player in these changes. There are currently no medications available to correct this chemical imbalance.
UTMB pharmacology and toxicology professors Jia Zhou, Kathryn Cunningham and their colleagues found that the serotonin 2C receptors in drug addicts do not work as well as they should. They designed, synthesized and pharmacologically evaluated a series of small molecule therapeutics designed to restore the weakened signaling.
The researchers trained rats to press on a lever for cocaine infusions at certain light cues. Once the rats learned this cocaine-seeking behavior, half of them received the most promising therapeutic and the other half received only saline.
The animals treated with the new therapeutic pressed the lever for cocaine far fewer times than the saline-treated control animals, even when reinforced with the cocaine-associated light cues.
Advertisement
"We will continue to optimize the chemical structure and effectiveness of our new therapeutic and conduct safety testing in cellular and animal studies," said Zhou. "We look forward to the future when we can begin clinical trials so that this therapeutic can begin to help people free themselves from drug addiction and other health issues."
Advertisement